Carbaglu is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases. The primary component is Carglumic Acid.
Product ID | 52276-312_2214969d-cb0e-438d-b329-c78e72d0198b |
NDC | 52276-312 |
Product Type | Human Prescription Drug |
Proprietary Name | Carbaglu |
Generic Name | Carglumic Acid |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-03-18 |
Marketing Category | NDA / NDA |
Application Number | NDA022562 |
Labeler Name | Recordati Rare Diseases |
Substance Name | CARGLUMIC ACID |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-03-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022562 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-03-18 |
Marketing Category | NDA |
Application Number | NDA022562 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-03-18 |
Ingredient | Strength |
---|---|
CARGLUMIC ACID | 200 mg/1 |
SPL SET ID: | 10175e73-5172-4dde-a508-8a88b7afc0a1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
52276-312 | Carbaglu | Carglumic Acid |
35573-459 | Carglumic acid | Carglumic acid |
68475-006 | Carglumic acid | Carglumic acid |
70954-120 | Carglumic Acid | Carglumic Acid |
71863-114 | Carglumic Acid | Carglumic Acid |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CARBAGLU 76500798 2876444 Live/Registered |
RECORDATI ORPHAN DRUGS 2003-03-26 |